These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 4278196)

  • 1. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 2. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 3. Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Dec; 22(3):409-18. PubMed ID: 131667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pretransplant donor-specific transfusions in renal transplantation.
    Leivestad T; Flatmark A; Hirschberg H; Thorsby E
    Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of renal transplant recipients using immunologic monitoring.
    Miller J; Kyriakides G; Flaa C
    Transplant Proc; 1979 Mar; 11(1):360-3. PubMed ID: 156425
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine.
    Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating antibodies in allograft recipients.
    Revillard JP; Betuel H
    Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible rejection of an HL-A identical sibling renal allograft.
    d'Apice JF; Morris PJ; Kincaid-Smith P; Mathew TH; Marshall VC
    Med J Aust; 1976 Feb; 1(7):195-7. PubMed ID: 131902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The beneficial role of blood transfusion and preganancy in the survival of renal allografts].
    Buy-Quang D; Soulillou JP; Fontenaille C; Guimbretière J; Guenel J
    Nouv Presse Med; 1977 Nov; 6(38):3503-7. PubMed ID: 341078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic patients immunized with planned blood transfusions: detection of HLA antibodies with the cytotoxic test and an indirect rosette microassay.
    Indiveri F; Fagiolo U; Pellegrino MA; Ferrone S
    Transplant Proc; 1979 Mar; 11(1):167-70. PubMed ID: 377624
    [No Abstract]   [Full Text] [Related]  

  • 11. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
    Fehrman I
    Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
    [No Abstract]   [Full Text] [Related]  

  • 12. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.
    Rashid A; Sengar DP; Harris JE
    Clin Exp Immunol; 1979 Jun; 36(3):521-7. PubMed ID: 158449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cell mediated lympholysis by peripheral blood lymphocytes from renal allograft recipients.
    Grunnet N; Kristensen T
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):41-4. PubMed ID: 133456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretransplant platelet transfusions: their effects on renal allograft outcome and mixed lymphocyte culture reactivity.
    Cahen R; Friedel AC; Betuel H; Adeleine P; Robert F; Trolliet P; Francois B
    Transplantation; 1993 Jun; 55(6):1428-31. PubMed ID: 8516830
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.